ARTICLE | Company News
Innovus, Prospector Capital Partners II LLC sales and marketing update
February 18, 2013 8:00 AM UTC
Innovus signed a binding term sheet to acquire nine prescription products approved in the U.S. from Prospector Capital. The products include Zytopic triamcinolone acetonide for atopic dermatitis, Cora...